Skip to content

Wyon Swiss Batteries, equipped with high-performance single crystal cathode active material, have been supplied by eJoule.

High-Performance Single Crystal Cathode Active Material Swiss Batteries Supplied by eJoule, Based in Fremont, California, and Appenzell Steinigg, Switzerland.

Wyon Swiss Batteries receive high-performance single crystal cathode active material from eJoule,...
Wyon Swiss Batteries receive high-performance single crystal cathode active material from eJoule, ensuring top-tier energy storage capabilities.

Wyon Swiss Batteries, equipped with high-performance single crystal cathode active material, have been supplied by eJoule.

eJoule Inc, a leading materials engineering company, has made a significant stride in the medical device battery market with their innovative single crystal cathode active material. This advancement offers high-performance lithium-ion cathode particles produced directly from solution phase droplets, thanks to their proprietary Dynamic Crystallization Process (DCP®).

The DCP process eliminates the need for traditional precursors, providing precise control over dopant composition and coatings, which is crucial for achieving outstanding battery performance.

Benefits of eJoule's Single Crystal Cathode

eJoule's single crystal cathode material offers several key benefits for medical device batteries:

  1. Enhanced long-term stability and consistent batch-to-batch quality are crucial for medical applications where reliability over time is non-negotiable.
  2. Improved energy density, cycle life, and thermal performance directly influence the capability and safety of lithium-ion micro-batteries used in critical medical implants and portable devices.
  3. Exceptional thermal stability and proven biocompatibility support safe operation in implantable systems such as hearing devices and other life-sustaining technologies.
  4. The scalable and modular DCP production method ensures uniform metal and dopant incorporation, eliminating variability common in traditional manufacturing methods, enhancing the reproducibility and performance consistency of cathode materials.

Partnership with Wyon Swiss Batteries

This technology enables battery manufacturers such as Wyon Swiss Batteries to tailor their lithium-ion micro-batteries specifically for demanding medical environments, where safety, durability, and miniaturization are imperative.

Philipp Wyser, CEO of Wyon AG, stated that eJoule's cathode material meets the world-class specifications and performance standards that Wyon demands for its proprietary lithium-ion batteries used in medical applications.

Liang Chen, Ph.D., CEO of eJoule Inc, stated that their proprietary process eliminates the need for traditional precursors by producing single crystal cathode particles directly from solution phase droplets.

This partnership between eJoule and Wyon Swiss Batteries reflects their shared commitment to advancing safe, high-performance energy solutions for next-generation healthcare technologies.

Advancing Next-Generation Healthcare

By advancing battery technology with single crystal cathode materials, eJoule supports next-generation healthcare by powering devices that provide improved patient outcomes and more accessible healthcare solutions.

eJoule Inc has fulfilled a multi-ton bulk order of high-performance doped and coated single crystal cathode active material, marking an important step in eJoule's scale-up efforts for cathode materials aimed at the medical battery market.

Advances in portable medical devices, together with the high-capacity batteries that power them, improve patient outcomes. The cathode material produced by eJoule's DCP process is the cathode of choice in Wyon's rechargeable micro-batteries, known for their reliability, thermal stability, and proven biocompatibility.

In these applications, long-term stability, batch-to-batch consistency, and safety are non-negotiable. The cathode material supplied by eJoule to Wyon Swiss Batteries is a high-performance single crystal cathode active material, tailored to the stringent specifications of Wyon Swiss Batteries.

The DCP Dynamic Crystallization Process used by eJoule is a closed-loop, modular, and scalable method for converting droplets of engineered chemical solutions into cathode powder in one thermal step. This process, along with eJoule's single crystal cathode active material, is set to revolutionise the medical device battery market, delivering high performance, reliability, and safety through novel manufacturing and materials engineering innovations.

The DCP process used by eJoule Inc, a key advantage in their single crystal cathode production, allows for precise control over dopant composition and coatings, essential factors for achieving outstanding battery performance in both science and technology.

The partnership between eJoule Inc and battery manufacturer Wyon Swiss Batteries brings together two pioneers in their respective fields, aiming to advance safe, high-performance energy solutions through science and technology for next-generation healthcare technologies.

Read also:

    Latest